Public, NASDAQ:DEPO
NASDAQ Global Market
Stock Market News Briefs: Brown amp; Brown, O'Charley's, Consolidated ...
Date: Tue, 07 Feb 2012 14:54:54 GMT
Tags:
Stock Market News Briefs: Brown amp; Brown, O'Charley's, Consolidated ...
Daily Markets (blog) - 20 hours ago
Daily Markets (blog) - 20 hours ago
Pharma company Depomed Inc's. (NASDAQ:DEPO) shares advanced 5.37% after the company said it would receive royalties from Merck & Co's (NYSE:MRK) type 2 diabetes drug, Janumet XR Share prices of HCA Holdings Inc. (HCA) rose 7.33% to close at $28.40 ...
Company News for February 7, 2012
Date: Tue, 07 Feb 2012 14:50:59 GMT
Tags:
Company News for February 7, 2012
InvestorIdeas.com (press release) - 20 hours ago
InvestorIdeas.com (press release) - 20 hours ago
• Pharma company Depomed Inc's. (NASDAQ:DEPO) shares advanced 5.37% after the company said it would receive royalties from Merck & Co's (NYSE:MRK) type 2 diabetes drug, Janumet XR • Share prices of HCA Holdings Inc. (NYSE:HCA) rose 7.33% to close at ...
Brown & Brown, Medco Health, Sprint, Sysco: U.S. Equity Movers
Date: Mon, 06 Feb 2012 22:12:59 GMT
Tags:
Brown & Brown, Medco Health, Sprint, Sysco: U.S. Equity Movers
San Francisco Chronicle - Feb 6, 2012
San Francisco Chronicle - Feb 6, 2012
Feb. 6 (Bloomberg) -- Shares of the following companies had unusual moves in US trading. Stock symbols are in parentheses, and prices are as of 4 pm in New York.
Anacor, Humana, Lazard, O'Charley's: US Equity Movers - BusinessWeekAmerican Apparel, Micron, MetLife, TiVo: US Equity Preview
Date: Mon, 06 Feb 2012 14:52:13 GMT
Tags:
American Apparel, Micron, MetLife, TiVo: US Equity Preview
BusinessWeek - Feb 6, 2012
BusinessWeek - Feb 6, 2012
Feb. 5 (Bloomberg) -- Shares of the following companies may have unusual moves in US trading tomorrow. Stock symbols are in parentheses.
American Apparel, Micron, MetLife, TiVo: U.S. Equity Preview - BloombergDepomed (DEPO) Receives $10M in JANUMET XR Approval by FDA (MRK)
Date: Mon, 06 Feb 2012 14:02:15 GMT
Tags:
Depomed (DEPO) Receives $10M in JANUMET XR Approval by FDA (MRK)
StreetInsider.com (subscription) - Feb 6, 2012
StreetInsider.com (subscription) - Feb 6, 2012
Depomed, Inc. (Nasdaq: DEPO) announced that Merck (NYSE: MRK) disclosed on February 2, 2012 that the US Food and Drug Administration (FDA) approved JANUMET XR (sitagliptin and metformin hydrochloride (HCl) extended-release) tablets, a new treatment for ...
6 Stocks That Outstretch LULU
Date: Tue, 07 Feb 2012 16:01:27 GMT
Tags:
Company News for February 7, 2012
Date: Tue, 07 Feb 2012 14:45:23 GMT
Tags:
Monday’s biggest gaining and declining stocks
Date: Mon, 06 Feb 2012 19:29:45 GMT
Tags:
American Apparel, Micron, MetLife, TiVo: U.S. Equity Preview
Date: Sun, 05 Feb 2012 17:05:54 GMT
Tags:
Micron, Depomed: After-Hours Trading (Update 1)
Date: Sat, 04 Feb 2012 00:26:06 GMT
Tags: